CLINICAL_TRIALS ClinicalTrials.gov record update

Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04476979
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:29.023310+00:00
Published At: 2024-05-31T00:00:00+00:00
Record Updated At: 2024-05-31
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Coronavirus Infection", "SARS (Severe Acute Respiratory Syndrome)", "Virus Diseases", "Coronaviridae Infections", "Nidovirales Infections", "RNA Virus Infections", "Respiratory Tract Infections", "Respiratory Tract Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-05-31"
protocolSection.identificationModule.nctId: "NCT04476979"
protocolSection.identificationModule.officialTitle: "Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.